Observational Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 28, 2021; 27(20): 2630-2642
Published online May 28, 2021. doi: 10.3748/wjg.v27.i20.2630
Inflammatory bowel disease in Tuzla Canton, Bosnia-Herzegovina: A prospective 10-year follow-up
Emir Tulumović, Nermin Salkić, Denijal Tulumović
Emir Tulumović, Nermin Salkić, Department of Gastroenterology and Hepatology, University Clinical Center Tuzla, Tuzla 75000, Tuzlanski Kanton, Bosnia and Herzegovina
Denijal Tulumović, Department of Nephrology, Dialysis and Transplantation, University Clinical Center Tuzla, Tuzla 75000, Tuzlanski Kanton, Bosnia and Herzegovina
Author contributions: Tulumović E contributed to data collection and analysis, and writing of the first draft of the paper; Salkić N contributed to study design and patient recruitment; Tulumović D contributed to data analysis and writing of the first draft of the paper; Salkić N and Tulumović D revised the article critically for important intellectual content.
Institutional review board statement: The study was reviewed and approved by the Ethical Board of University Clinical Center Tuzla by the declaration 02-09/2-78/20, on the 01.12.2020.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that there is no conflict of interest related to this manuscript.
Data sharing statement: The data underlying this article cannot be shared publicly, as it is provided with permission of University Clinical Center Tuzla. The data will be shared on reasonable request to the corresponding author with the permission of University Clinical Center Tuzla.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Emir Tulumović, MD, Doctor, Department of Gastroenterology and Hepatology, University Clinical Center Tuzla, Ibre Pašića bb, Tuzla 75000, Tuzlanski Kanton, Bosnia and Herzegovina. emir.tulumovic@ukctuzla.ba
Received: January 24, 2021
Peer-review started: January 24, 2021
First decision: March 7, 2021
Revised: March 15, 2021
Accepted: April 22, 2021
Article in press: April 22, 2021
Published online: May 28, 2021
Core Tip

Core Tip: The greatest gap in knowledge about the epidemiological picture of inflammatory bowel disease relates to developing countries, such as those in Eastern Europe. The heterogeneity between the results among the few available epidemiological studies concerning Eastern Europe is intriguing. Therefore, we aimed to perform a follow-up review of inflammatory bowel disease epidemiology in the Tuzla Canton of Bosnia-Herzegovina during a 10-year period (2009-2019).